908 organization(s) found
Takeda Oncology
Takeda Oncology is the Global Oncology Business Unit of Takeda Pharmaceutical Company. Our nearly three decades of leadership in oncology reflect a commitment to advancing treatment options that enhance and extend the lives of people living with a range of cancers. We're working to ensure that patients everywhere can access and benefit from our portfolio of approved medicines and developing new treatment options for patients with unmet needs. Our pipeline focuses on thoracic, gastrointestinal and hematologic cancers and our core modalities include antibody-drug conjugates (ADCs), complex biologics and small molecules. We see great value in advancing innovation through collaboration with partners who share our aspiration to cure cancer. Together, we strive to bring life-changing medicines to more patients worldwide.
Talus Bio
Talus' technology measures and modulates the regulome in its native context. Our proprietary platform unlocks the ability to design interventions at the root of cellular decision making.
TAPCCO (Tesfa Addis Parents Childhood Cancer Organization)
Vision: To see children contracting pediatrics cancer get treatment and cure for the disease. Objectives: To improve the quality of life for children with cancer, support their families and assist pediatric cancer hematology/oncology facilities to be centers of excellence. Mission: To increase the curability rate of pediatrics cancer through parents’ involvement and improving the quality of services in the treatment, diagnostic and follow – up works. Background: Tesfa Addis Parents Childhood Cancer Organization (TAPCCO) is a Non-profit Organization (NPO) established by parents of children with cancer and individuals interested in helping children with cancer and their families on December 5, 2012 under Charities and Societies proclamation No. 621/2009 Ethiopian Resident Charity License No. 2920 and re-registered under proclamation no. 1113/2019 on May 16, 2019.
TCA (Tunisia Cancer Association)
Promotes cancer awareness and prevention in Tunisia through education campaigns.
TCCF (Tanzania Cancer Care Foundation)
Provides awareness campaigns, screening programs, and patient support services.
Telix Pharmaceuticals
Delivering on the promise of precision medicine through targeted radiation: Telix is a global, commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals.
Tempus AI
Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data. We enable physicians to make real-time, data-driven decisions to deliver personalized care and targeted therapies for patients through our analytical machine learning platform that uses the power of artificial intelligence in healthcare. We also work with partners to facilitate discovery, development, and delivery of optimized therapeutics.
Terremoto Biosciences
Delivering Medicines with Superior Therapeutic Benefit for Patients We develop groundbreaking, best-in-class precision therapies to meet urgent patient needs. Through relentless science and deep purpose, we bring life-changing hope to those who need it most.
Terumo Blood and Cell Technologies
Company that makes apheresis, blood component and cell therapy processing systems.
Texas Children's Hospital
US pediatric hospital with a large cancer and hematology centre.
The Francis Crick Institute
Biomedical research institute in London.
The Hospital for Sick Children (SickKids)
Canadian pediatric hospital and research institute.
The Johns Hopkins Hospital
For more than 125 years, The Johns Hopkins Hospital has been a leader in the diagnosis and treatment of disease. Above all, we aim to provide the highest-quality health care and service to all our patients. As the teaching hospital affiliated with the Johns Hopkins University School of Medicine, we are located in the heart of East Baltimore. The hospital includes the Johns Hopkins Children’s Center and the Johns Hopkins Kimmel Cancer Center.
The Mark Foundation for Cancer Research
US foundation that funds cancer research worldwide, from basic science to early translation.